* Prestige Consumer Healthcare Inc PBH.N PBH is expected
to show a rise in quarterly revenue when it reports results on
February 8 for the period ending December 31 2023
* The Tarrytown New York-based company is expected to
report a
1.7% increase in revenue to $280.25 million from $275.52 million
a year ago, according to the mean estimate from 6 analysts,
based on LSEG data.The company's guidance on November 2 2023,
for the period ended December 31, was for revenue of $280.000
million.
* LSEG's mean analyst estimate for Prestige Consumer
Healthcare
Inc is for earnings of $1.04 per share.
* The current average analyst rating on the shares is "buy"
and
the breakdown of recommendations is 5 "strong buy" or "buy," 1
"hold" and no "sell" or "strong sell."
* The mean earnings estimate of analysts was unchanged in
the last
three months.
* Wall Street's median 12-month price target for Prestige
Consumer
Healthcare Inc is $71.00, above its last closing price
of $61.84.
Previous quarterly performance (using preferred earnings measure
in US dollars).
QUARTER STARMINESM LSEG IBES ACTUAL BEAT, SURPRI
ENDING ARTESTIMAT ESTIMATE MET, SE %
E® MISSED
Sep. 30 2023 1.07 1.07 1.07 Met 0.3
Jun. 30 2023 1.01 1.01 1.06 Beat 5
Mar. 31 2023 1.04 1.04 -4.83 Missed -564.4
Dec. 31 2022 1.01 1.01 1.04 Beat 2.6
Sep. 1.00 1.00 1.02 Beat 1.8
30 2022
Jun. 30 2022 1.04 1.04 1.09 Beat 5
Mar. 31 2022 0.89 0.89 0.91 Beat 2.6
Dec. 31 2021 0.88 0.88 0.99 Beat 12.1
This summary was machine generated February 6 at 13:55 GMT. All
figures in US dollars unless otherwise stated. (For questions
concerning the data in this report, contact
Estimates.Support@lseg.com. For any other questions or feedback,
contact RefinitivNewsSupport@thomsonreuters.com)